| http://1828.mshaffer.com |
Wednesday - February 8, 2012 |
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
|---|
In celebration of Noah Webster's Birthday (October 16, 2009), we have prepared an updated website. Please update your bookmarks: http://www.1828-dictionary.com/d/word/incomparable |
|||||||||||||||||||||||||||||||||
Why Donate?Here are a number of reasons:
Donate Using PayPalIf you have a major credit card (Visa, MasterCard, American Express) or a PayPal account, donating is easy. Just click the dollar amount below to donate:
Donations from Outside of the United StatesWe welcome donations from anywhere in the world and in any currency. PayPal accepts a number of international currencies. Donations by Other MethodsIf you wish to donate via direct bank deposit or mail a cheque or money order, please email me . |
|
||||||||||||||||||||||||||||||||
|
The Japanese commissioner in Washington DC in the 1900's studying the American patent system said, "We have looked about us to see what nations are the greatest, so that we can be like them... We said, 'What makes the United States such a great nation?' and we investigated and found that it was patents, and we will have patents." Proper organization of a patent porfolio is essential to be prepared to properly navigate the IP landscape. One key issue is related to inventorship. Consider the Pfizer patent, patent # 5,760,06^, which is commonly known as the COX-2 inhibitor. Pfizer is currently in a $1B lawsuit because Searle, the original owner of the patent, failed to include a key inventor on the patent. Pfizer inherited this mess when they acquired Pharmacia, who had previously acquired Monsanto, who had previously acquired Searle. Ignorance is not a defensible excuse in patent litigation. In Nortel's recent bankrupcy, the liquidation of the IP assets led to a bidding war. Google offered $900M for the patents; Apple and Microsoft created an alliance (with RIM, Sony, EMC, Ericsson) to offer $4.5B for the same patents^. Certainly there was a great disparity in these bid prices. How can you objectively determine the value of a portfolio and patent duration. Let the tools at IPstreet.com help you. |